Mettler ToledoMTDEarnings & Financial Report
Mettler Toledo, stylized in all caps, is a multinational supplier of precision instruments and services. The company focuses on laboratory, industrial, product inspection, and food retailing applications. Its products are used in research, quality control, and manufacturing processes in life sciences, food, chemical, and many other industries.
売上高
$942.5M
粗利益
$559.5M
営業利益
N/A
純利益
$201.6M
粗利益率
59.4%
営業利益率
N/A
純利益率
21.4%
前年比成長
-4.4%
EPS
$9.21
資金フロー
Mettler Toledo Q3 2023 Financial Summary
Mettler Toledo reported revenue of $942.5M for Q3 2023, with a net profit of $201.6M (21.4% margin). Cost of goods sold was $382.9M, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $942.5M |
|---|---|
| Net Profit | $201.6M |
| Gross Margin | 59.4% |
| Operating Margin | N/A |
| Report Period | Q3 2023 |
Mettler Toledo Annual Revenue by Year
Mettler Toledo annual revenue history includes year-by-year totals (for example, 2025 revenue was $4.0B).
| Year | Annual Revenue |
|---|---|
| 2025 | $4.0B |
| 2024 | $3.9B |
| 2023 | $3.8B |
| 2022 | $3.9B |
損益計算書
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $925.9M | $946.8M | $954.5M | $1.05B | $883.7M | $983.2M | $1.03B | $1.13B |
| 前年比成長 | -0.3% | -3.6% | 1.3% | 11.8% | -4.6% | 3.9% | 7.9% | 8.1% |
貸借対照表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $3.28B | $3.25B | $3.32B | $3.24B | $3.23B | $3.40B | $3.52B | $3.71B |
| 総負債 | $3.44B | $3.40B | $3.47B | $3.37B | $3.42B | $3.66B | $3.77B | $3.74B |
| 株主資本 | $-158.7M | $-152.8M | $-154.4M | $-126.9M | $-182.0M | $-258.8M | $-249.2M | $-23.6M |
キャッシュフロー
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $190.0M | $257.5M | $254.7M | $266.2M | $194.4M | $236.4M | $299.4M | $225.6M |
Other Health Care Companies
A
Agilent Technologies
売上高
$1.9B
純利益
$434.0M
TECH
Bio-Techne
売上高
$295.9M
純利益
$38.0M
CRL
Charles River Laboratories
売上高
$994.2M
純利益
$-276.6M
DHR
Danaher Corporation
売上高
$6.1B
純利益
$908.0M
IQV
IQVIA
売上高
$4.4B
純利益
$514.0M
TMO
Thermo Fisher Scientific
売上高
$11.1B
純利益
$1.6B
ABT
Abbott Laboratories
売上高
$11.4B
純利益
$1.6B
ABBV
AbbVie
売上高
$15.8B
純利益
$186.0M
ALGN
Align Technology
売上高
$995.7M
純利益
$56.8M
AMGN
Amgen
売上高
$9.9B
純利益
$1.3B